Limbal allograft transplantation was performed consecutively in 16 eyes with thermal or chemical burns (n = 5), Terrien's degeneration (n = 2), congenital sclerocornea (n = 1), Stevens-Johnson syndrome (n = 1), and chronic keratoconjunctivitis (n = 7), by transplanting randomly selected cadaver limbocorneal grafts to the recipient eye that had received superficial lamellar keratectomy to remove fibrovascular pannus. Oral cyclosporine A was administered immediately for 2.9 ± 1.3 months. During 18.5 ± 5.4 months of follow-up, the results showed improved visual acuity in 13 eyes (81.3%) and rapid (within 1 week) surface healing in 10 eyes (62.5%). Donor limbal tissue developed engorged and tortuous blood vessels in 12 eyes within 1-2 months, but these regressed within 3 months after surgery. No acute graft failure or allograft rejection could be identified. Twelve eyes (75%) showed total regression of vascularization and four eyes had decreased vascularization. These preliminary results indicate that limbal allograft transplantation may be able to reconstruct a corneal surface that has undergone bilateral diffuse destruction, including the loss of limbal epithelial stem cells.
Human Allograft Limbal Transplantation for Corneal Surface Reconstruction
Ray Jui-Fang Tsai, M.D., and Scheffer C.G. Tseng, M.D., Ph.D.
Limbal allograft transplantation was performed consecutively in 16 eyes with thermal or chemical burns (n = 5), Terrien's degeneration (n = 2), congenital sclerocornea (n = 1), Stevens-Johnson syndrome (n = 1), and chronic keratoconjunctivitis (n = 7), by transplanting randomly selected cadaver limbocorneal grafts to the recipient eye that had received superficial lamellar keratectomy to remove fibrovascular pannus. Oral cyclosporine A was administered immediately for 2.9 ± 1.3 months. During 18.5 ± 5.4 months of follow-up, the results showed improved visual acuity in 13 eyes (81.3%) and rapid (within 1 week) surface healing in 10 eyes (62.5%). Donor limbal tissue developed engorged and tortuous blood vessels in 12 eyes within 1-2 months, but these regressed within 3 months after surgery. No acute graft failure or allograft rejection could be identified. Twelve eyes (75%) showed total regression of vascularization and four eyes had decreased vascularization. These preliminary results indicate that limbal allograft transplantation may be able to reconstruct a corneal surface that has undergone bilateral diffuse destruction, including the loss of limbal epithelial stem cells. Key Words: Allograft transplantation-Corneal surface-Cyclosporine A-Limbus corneae-Stem cells.
For corneal surface reconstruction, limbal transplantation is a new procedure modified from that of conjunctival transplantation, first described by Thoft (1, 2) , by incorporating the new concept of limbal stem cells [see review by Tseng (3)]. This surgical procedure, first reported by Kenyon and Tseng (4), was effective in reconstructing a corneal Submitted August 11, 1993 . Revised January 10, 1994 . Accepted January 11, 1994 . surface that had previously been damaged from chemical or thermal injuries, contact lens-induced keratopathy, or multiple surgeries. All of these ocular surface disorders are characterized by the loss of limbal stem cells, a condition termed limbal deficiency. Using a rabbit model, we have recently shown that limbal transplantation is more effective than conjunctival transplantation in reconstructing a corneal surface that has previously been damaged by combined chemical and mechanical scraping of total corneal epithelium and ring lamellar removal of limbal tissues (5). Without transplantation, partial (6,7) or total (8,9) removal of the limbal epithelium in a manner similar to the above rabbit model results in abnormal corneal epithelial wound healing, and eventually the limbal deficiency that constitutes a constellation of problems: conjunctival epithelial ingrowth (conjunctivalization), vascularization, and chronic inflammation [see review by Tseng et al. (10)]. The fact that transplantation of limbal tissue can restore the corneal epithelial phenotype together with regression of corneal vascularization and inflammation (4,5) further supports the validity of the concept of limbal stem cells.
The original procedure of limbal transplantation used an autologous source of limbal tissue (4,5), and thus is only feasible for cases with unilateral or focal damage, and not applicable to those with bilateral diffuse involvement. Furthermore, according to a recent study by Chen and Tseng (6), partial removal of the full-thickness limbal zone in a manner similar to that of a donor eye receiving autograft limbal transplantation will compromise the resultant corneal surface, which can be decompensated and develop limbal deficiency when a large corneal epithelial defect is introduced later. As a matter of fact, even the removal of partial-thickness limbal epithelium can cause a milder form of limbal deficiency and abnormal corneal epithelial wound healing in the event of a large corneal epithelial defect (7). Although it is unknown whether a heterologous source of limbal tissue can also survive after transplantation due to its potential allograft rejection, the advantage of allograft limbal transplantation is obvious for cases with bilateral diffuse limbal deficiency.
For corneal surface reconstruction, Thoft and coworkers (11) have previously reported a surgical technique termed keratoepithelioplasty using lenticules taken from the peripheral donor cornea for patients with bilateral diffuse ocular surface diseases. Subsequently, they reported the use of keratoepithelioplasty to include the limbal epithelium (12), presumably based on the concept of limbal stem cells. They used this procedure to treat patients with chronic ocular surface failure that was unresponsive to conventional medical treatments. These include chemical/thermal injuries, Steven-Johnson syndrome, aniridia, atopic diseases, and benign hereditary intraepithelial dyskeratosis (12). Recently, Kinoshita et al. (13) reported encouraging results using keratoepithelioplasty in the treatment of Mooren's ulcers. In the latter report, some cases received large limbus-to-limbus grafts. For all these reports, topical steroid drugs but not systemic immunosuppressive agents have been used.
To examine its feasibility, allograft limbal transplantation was performed in a series of 16 eyes in 15 human cases with marked perilimbal fibrovascular ingrowth on the corneal surface. To eliminate any potential allograft rejection, oral cyclosporine was routinely administered. In this report, we describe our preliminary results.
MATERIALS AND METHODS

Surgical Indications
Allograft limbal transplantation was performed in 16 eyes of 15 patients (seven male and eight female patients), whose ages ranged from 8 to 65 (mean, 37 ± 15) years. As shown in Table 1 , these 16 eyes could be subdivided into: (a) thermal or chemical burns (>6 months after injury) (n = 5), (b) Terrien's peripheral corneal degeneration (n = 2), (c) congenital peripheral sclerocornea (n = 1), (d) Stevens- 
